JP2009521473A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521473A5
JP2009521473A5 JP2008547585A JP2008547585A JP2009521473A5 JP 2009521473 A5 JP2009521473 A5 JP 2009521473A5 JP 2008547585 A JP2008547585 A JP 2008547585A JP 2008547585 A JP2008547585 A JP 2008547585A JP 2009521473 A5 JP2009521473 A5 JP 2009521473A5
Authority
JP
Japan
Prior art keywords
composition
chlorite
weight ratio
unit dose
chlorate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008547585A
Other languages
English (en)
Japanese (ja)
Other versions
JP5371443B2 (ja
JP2009521473A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/048941 external-priority patent/WO2007075972A2/en
Publication of JP2009521473A publication Critical patent/JP2009521473A/ja
Publication of JP2009521473A5 publication Critical patent/JP2009521473A5/ja
Application granted granted Critical
Publication of JP5371443B2 publication Critical patent/JP5371443B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008547585A 2005-12-22 2006-12-21 亜塩素酸塩製剤、およびこの調製の方法と利用 Active JP5371443B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75349705P 2005-12-22 2005-12-22
US60/753,497 2005-12-22
PCT/US2006/048941 WO2007075972A2 (en) 2005-12-22 2006-12-21 Chlorite formulations, and methods of preparation and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013000170A Division JP5860821B2 (ja) 2005-12-22 2013-01-04 亜塩素酸塩製剤、およびこの調製の方法と利用

Publications (3)

Publication Number Publication Date
JP2009521473A JP2009521473A (ja) 2009-06-04
JP2009521473A5 true JP2009521473A5 (enExample) 2010-02-12
JP5371443B2 JP5371443B2 (ja) 2013-12-18

Family

ID=38218646

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008547585A Active JP5371443B2 (ja) 2005-12-22 2006-12-21 亜塩素酸塩製剤、およびこの調製の方法と利用
JP2013000170A Expired - Fee Related JP5860821B2 (ja) 2005-12-22 2013-01-04 亜塩素酸塩製剤、およびこの調製の方法と利用
JP2014165700A Withdrawn JP2014210817A (ja) 2005-12-22 2014-08-18 亜塩素酸塩製剤、およびこの調製の方法と利用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013000170A Expired - Fee Related JP5860821B2 (ja) 2005-12-22 2013-01-04 亜塩素酸塩製剤、およびこの調製の方法と利用
JP2014165700A Withdrawn JP2014210817A (ja) 2005-12-22 2014-08-18 亜塩素酸塩製剤、およびこの調製の方法と利用

Country Status (6)

Country Link
US (5) US8067035B2 (enExample)
EP (1) EP1979269A4 (enExample)
JP (3) JP5371443B2 (enExample)
AU (1) AU2006331497B2 (enExample)
CA (2) CA2919344C (enExample)
WO (1) WO2007075972A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110027330A1 (en) * 2005-03-01 2011-02-03 Martin Roy W Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications
US8067035B2 (en) 2005-12-22 2011-11-29 Neuraltus Pharmaceuticals, Inc. Chlorite formulations, and methods of preparation and use thereof
EP2517713A3 (en) 2007-06-01 2013-01-30 Nuvo Research AG A method of treating allergic asthma, allergic rhinitis and atopic dermatitis
AU2010281524A1 (en) * 2009-08-06 2012-02-23 Neuraltus Pharmaceuticals, Inc. Treatment of macrophage-related disorders
US20130136805A1 (en) * 2010-08-13 2013-05-30 Servet Buyuktimkin Foamable compositions of stabilized chlorite
FR2968559B1 (fr) 2010-12-14 2012-12-28 Alexandra Fregonese Nouvelles compositions a base d'argile et de beepollen, leur procede de preparation et leurs utilisations en nutrition et en therapeutique
DE102010055771A1 (de) * 2010-12-23 2012-06-28 KyroChem GmbH Chlorithaltige Zusammensetzung
WO2012106822A1 (en) * 2011-02-09 2012-08-16 Nuvo Research Ag. Wound dressings comprising chlorite
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US20130177629A1 (en) * 2011-12-22 2013-07-11 Nuvo Research Gmbh Liposomal compositions
EP2804612A4 (en) * 2012-01-19 2015-09-02 Ibt Pharma Inc THERAPEUTIC USES OF TETRACHLORODECAOXYGEN (TCDO)
JP2015071581A (ja) * 2013-05-20 2015-04-16 本部三慶株式会社 亜塩素酸水含有ウイルス殺傷剤
WO2015049110A1 (en) * 2013-10-03 2015-04-09 Umicore Ag & Co. Kg Exhaust aftertreatment system
WO2015181800A2 (en) * 2014-05-30 2015-12-03 Nuvo Research Ag Methods for purifying chlorites and chlorates
WO2017079161A2 (en) 2015-11-02 2017-05-11 Neuraltus Pharmaceuticals, Inc. Treatment of neurodegenerative disease with sodium chlorite
DE102016007081A1 (de) * 2016-06-10 2017-12-14 Alethia Life Sciences Ag Chlordioxid Desinfektionstuch
WO2021235506A1 (ja) * 2020-05-21 2021-11-25 国立大学法人大阪大学 上皮癌治療薬
JP2024533873A (ja) 2021-10-04 2024-09-12 ニューヴィヴォ， インコーポレイテッド Ａｌｓ患者の処置方法
WO2023225125A1 (en) 2022-05-19 2023-11-23 Neuvivo, Inc. Biomarkers for neurogenerative disease
US20240367988A1 (en) * 2023-04-20 2024-11-07 Neuvivo, Inc. Chlorite compositions

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2129464A (en) * 1937-10-06 1938-09-06 Mathieson Alkali Works Inc Recovery of sodium chloride and sodium chlorite from aqueous solutions
US2169066A (en) 1938-07-01 1939-08-08 Mathieson Alkali Works Inc Preparation of sodium chlorate and sodium chlorite and the separation thereof
DE941665C (de) * 1951-04-19 1956-04-19 Val Mehler Segeltuchweberei Ag Verfahren zum Bleichen von Textilien
US3082146A (en) 1959-02-04 1963-03-19 Chemical Res Lab Of America In Process for the treatment of water
US4296103A (en) 1980-08-08 1981-10-20 Felipe Laso Stabilized solution of chlorine oxides
DE3213389A1 (de) * 1982-04-10 1983-10-20 Friedrich-Wilhelm Dr. 7107 Neckarsulm Kühne Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten
DE3515748A1 (de) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg Verwendung einer isotonen chloritmatrix-loesung bei der behandlung von tumoren
DE3515749A1 (de) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg Verwendung einer stabilisierten chloritmatrixloesung bei infektioesen zustaenden
DE3515745A1 (de) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg Waessrige chloritmatrix-loesung
US4944920A (en) 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
US4851222A (en) 1988-01-27 1989-07-25 Oxo Chemie Gmbh Method of promoting regeneration of bone marrow
US5078908A (en) * 1989-10-02 1992-01-07 Allergan, Inc. Methods for generating chlorine dioxide and compositions for disinfecting
DE4208828A1 (de) * 1992-03-19 1993-09-23 Oxo Chemie Gmbh Verwendung einer chemisch stabilisierten chloritmatrix zur herstellung von arzneimitteln zur behandlung von hiv-infektionen
US5622725A (en) * 1992-03-20 1997-04-22 Alcide Corporation Wound disinfection and repair
GB9208731D0 (en) * 1992-04-22 1992-06-10 Squibb & Sons Inc Hydrocolloid wound gel
US5830511A (en) 1992-06-25 1998-11-03 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
US6099855A (en) 1992-06-25 2000-08-08 Bioxy, Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
ES2199956T3 (es) 1992-12-17 2004-03-01 Advanced Medical Optics, Inc. Solucion desinfectante de lentes de contacto que contiene un agente oxidante y polivinilpirrolidona.
JPH06230717A (ja) 1993-02-02 1994-08-19 Kanebo Ltd 骨模型
US5639295A (en) * 1995-06-05 1997-06-17 Southwest Research Institute Method of making a composition containing a stable chlorite source
US5489435A (en) * 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US5855922A (en) * 1995-12-07 1999-01-05 Bio-Cide International, Inc. Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders
US5723095A (en) * 1995-12-28 1998-03-03 Steris Corporation Cleaner concentrate formulation for biological waste fluid handling systems
US5877222A (en) 1996-07-19 1999-03-02 The Regents Of The University Of California Method for treating aids-associated dementia
ATE258799T1 (de) 1997-10-06 2004-02-15 Oxo Chemie Ag Verwendung einer chemisch stabilisierten chloritlösung zur inhibition der antigenspezifischen immunantwort
US6350438B1 (en) 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6132702A (en) * 1998-02-27 2000-10-17 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
EP1119347B1 (en) 1998-10-08 2005-03-02 Hampar L. Karagoezian Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
CN1433481A (zh) 1999-11-30 2003-07-30 奥克索化学有限公司 通过基因表达分析评价和预测临术预后
DE10012340A1 (de) * 2000-03-14 2001-09-20 Merck Patent Gmbh Verfahren zur Baeyer-Villiger-Oxidation organischer Carbonylverbindungen
WO2003025252A1 (en) * 2001-01-16 2003-03-27 Kelley Joseph M An electrolytic process for the generation of stable solutions of chlorine dioxide
WO2002092028A2 (en) * 2001-05-15 2002-11-21 The Procter & Gamble Company Oral care compositions
ITMI20011702A1 (it) * 2001-08-03 2003-02-03 Acraf Soluzione disinfettante a base di ipoclorito di sodio e procedimento per prepararla
AU2002343609B2 (en) 2001-11-16 2008-12-11 Als Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
US7105183B2 (en) * 2004-02-03 2006-09-12 The Regents Of The University Of California Chlorite in the treatment of neurodegenerative disease
US8067035B2 (en) 2005-12-22 2011-11-29 Neuraltus Pharmaceuticals, Inc. Chlorite formulations, and methods of preparation and use thereof
WO2016038678A1 (ja) 2014-09-09 2016-03-17 三菱電機株式会社 エレベータの機器取付装置

Similar Documents

Publication Publication Date Title
JP2009521473A5 (enExample)
CN116075306B (zh) 用于治疗冠状病毒感染的化合物
US11072648B2 (en) Mast cell stabilizers for treatment of fever
RU2361593C3 (ru) Комбинация азеластина и стероидов
JP2004519469A5 (enExample)
KR20150011807A (ko) 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
JP2002519318A5 (enExample)
US20100209540A1 (en) Inhalation formulation for treating and prophylactic use in bacteria, mycobacterial and fungal respiratory infections
JP5653466B2 (ja) フルニソリド含有粘膜適用組成物
JP2013508282A (ja) ウイルス感染のための併用療法処置
JP2007532607A5 (enExample)
CA2991156A1 (en) Compositions and methods for the treatment of viral infection
US20150034087A1 (en) Low Dose Pharmaceutical Composition Comprising Zanamivir
JP2008540506A5 (enExample)
CN103446051A (zh) 含有帕拉米韦和/或其衍生物制剂的给药方法
US20240075029A1 (en) Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection
JP2021119164A5 (enExample)
EP3981405A1 (en) Compound for the treatment of coronaviral infections
JP2010189301A (ja) 新型インフルエンザ感染症に対する医薬組成物およびその利用
JP2009538822A5 (enExample)
JP2023524064A (ja) ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法
JP2009533428A (ja) 筋肉内抗ウイルス処置
JP2013542262A5 (enExample)
JP2009507850A5 (enExample)
WO2025067689A1 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus